Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ACAD
— ACADIA Pharmaceuticals Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2025 Earnings Call Summary
NOV 6, 2025
REVENUE
$278.6M
+5.3%
NET MARGIN
25.8%
+15.7 PTS
EPS
$0.43
+168.8%
FREE CASH FLOW
$73.9M
-54.5%
No summary has been written for this call yet.
← NEWER CALL
CALL 4 OF 4
OLDER CALL →